ArticleJournal of shoulder and elbow arthroplasty2026
Clinical and radiological results of custom-made glenoid implants in reverse total shoulder arthroplasty with a mean follow-up of 36 months.
Article in Journal of shoulder and elbow arthroplasty, 2026. The graph could read no effect estimate from its abstract, so it casts no vote on the map. Not yet cited in PubMed.
What it found
Each row is one number read from the abstract, on the scale the paper reported it, with its interval. Left of the dashed line favours the treatment, right favours the comparator. Under each row is the sentence it came from. New to these charts? A ten-minute tutorial.
The abstract states no effect estimate the extractor could read, or names no intervention and outcome on the map, so this paper lights no cell and moves no belief. It is still indexed, cited and linked below.
The trial behind it
Trials whose registry record cites this paper, or whose number appears in the abstract. A trial that started after this paper was published is citing it as background, not reporting it.
Neither the registry nor the abstract names a trial number. If this is a trial report, that itself is worth knowing.
Who cites it
0 citing papers in PubMed.
No citing paper in PubMed yet.
Corrections and comments
PubMed lists nothing against this paper. Absence here is not a guarantee, only a check that was made.
Authors and funding
3 authors.
Funding
No grant is acknowledged in the PubMed record.
Abstract
Background: Custom-made glenoid implants (CMGIs) represent a new technology for treating severe glenoid bone deficiencies. Despite the potential advantages of achieving sufficient primary stability and precise implant positioning, its role is not clear due to the scarcity of clinical studies. Methods: The first 12 consecutive patients who were treated with CMGIs (ProMade, Enovis) at a single institution were enrolled. At a minimum follow-up (FU) of 2 years (range: 24-76 months; mean 36 months), the clinical outcomes were evaluated using the Constant score, Simple Shoulder Test, and range of motion and compared with pre-operative values. Radiographs were assessed for inferior notching, osteolysis, or other signs of loosening. All complications were recorded. Results: There was a significant improvement in Constant score (26 to 71 [ Conclusion: CMGIs are an option for the treatment of severe glenoid bone deficiencies at a short- to medium-term follow-up with promising clinical results and no adverse radiological signs. The complication rate is not insignificant, and further studies with longer-term follow-up are suggested.
Indexed as
Identifiers
What OpenQuestion holds
Registered trials
Read under generation 80e0d062 · epoch 390. Bibliography from PubMed, PubMed Central and OpenAlex; grants from NIH RePORTER; trial links from ClinicalTrials.gov; estimates, votes and beliefs from the OpenQuestion graph.